Skip to main content
Premium Trial:

Request an Annual Quote

The Race is On: Agilent, NimbleGen Take Up ABI s Challenge for First Whole-Genome Microarray

NEW YORK, July 28 - The race is on to see who will be the first to release a whole human genome single microarray - and then sell it.

 

Agilent Technologies today said it will release a single-chip whole human genome microarray later this year, BioArray News, GenomeWeb's microarray industry newsletter, has learned.

 

Additionally, Madison, Wis.-based Nimblegen, a microarray services provider using its proprietary platform, said today that it already has a single-chip whole human genome microarray available for researchers. For details, please click here to read BioArray News.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.